General News

FDA Seizes 7-OH Opioids Worth $1 Million

The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, has announced that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products valued at $1 million from three firms in Missouri.

FDA said the seizure focused on foods and dietary supplement products — including liquid shots and tablets — containing concentrated 7-OH as an added ingredient. Concentrated 7-OH is increasingly recognized as having potential for abuse because of its ability to bind to opioid receptors. It cannot be lawfully added to dietary supplements or conventional foods. These products are considered adulterated because 7-OH does not meet applicable safety standards. Also, the FDA has not approved 7-OH for medical use.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by Joji Xavier

For comments and feedback: contact editorial@rttnews.com

More General News